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ABSTRACT
Objectives: Despite medical advances, rising awareness, and satisfactory care facilities, placenta previa (PP) remains 
a challenging clinical entity due to the risk of excessive obstetric hemorrhage. Etiological concerns gave way to life-saving 
concerns about the prediction of maternal outcomes due to hemorrhage. Our study aimed to detect an early predictive 
marker of placenta previa.
Material and methods: Ninety-three pregnant patients diagnosed with PP and 247 controls were recruited for this retro-
spective study. Platelet and leukocyte indices were compared between the two groups.
Results: The groups were similar with regard to age distribution (31.2 ± 5.1 years [mean ± SD] in the PP group and 
31.7 ± 4.2 years in controls), body mass index (BMI) (27.7 ± 3.6 kg/m2 in the PP group and 27.4 ± 4.6 kg/m2 in controls), 
and most characteristics of the obstetric history. Total leukocyte count, neutrophil count, and neutrophil-to-lymphocyte 
ratio were significantly higher in the PP group. Mean platelet volume (MPV) and large platelet cell ratio (P-LCR) values were 
significantly lower in the PP group as compared to controls, with regard to third trimester values. However, patients who 
were diagnosed postnatally with placenta percreta had lower MPV and P-LCR values than other patients with PP. There were 
no statistically significant differences between the two groups as far as first trimester values were concerned.
Conclusions: Platelet and leukocyte indices in the third trimester of pregnancy may be valuable predictors of placenta 
previa and placenta percreta. More comprehensive studies are needed to address this issue.
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INTRODUCTION
Placenta previa (PP), defined as a placenta located 
on the internal os of the uterine cervix, may be the most 
dangerous cause of excessive obstetric hemorrhage and 
a life-threatening clinical entity. It sometimes has a storming 
effect during the delivery as the result of unanticipated cata-
strophic complications, e.g. excessive hemorrhage, the need 
for cesarean hysterectomy, or surgical complications (lacera-
tion of the urinary bladder, intestinal or vascular trauma). 
The diagnosis may be delayed due to the fact that PP may 
cause some mild complications which neither bother the 
patient nor alarm the clinician until the delivery, except for 
insignificant intermittent hemorrhage periods [1]. 
As the time of delivery approaches, questions about the 
prediction of adhesive placental abnormalities and possible 
blood loss begin to appear. Ultrasonography and magnetic 
resonance imaging (MRI) have been proven to be useful 
in predicting and lessening the complications of placenta 
previa but, as most screening methods, they are not without 
pitfalls either [2]. 
OBJECTIVES 
The literature offers some reports on the prediction of 
placenta previa but, to the best of our knowledge, leukocyte 
and platelet indices have never been studied in that context. 
Therefore, we aimed to detect an early predictive marker of 
placenta previa and adhesive placental abnormalities using 
simple laboratory variables. 
MATERIAL AND METHODS
A total of 321 patients diagnosed with placenta previa 
(PP) and 389 patients diagnosed with low-risk pregnancy, 
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admitted to the Zekai Tahir Burak Women’s Health Care Train-
ing and Research Hospital in Ankara, Turkey, between Janu-
ary 2011 and December 2013 for delivery, were analyzed 
retrospectively in this case-control study. The diagnoses 
and laboratory results were obtained from patient medical 
records. The diagnosis of PP was made if the lower edge of 
placental tissue was within 20 mm of the internal cervical os, 
or it overlapped it on transvaginal ultrasonographic exami-
nation. Placenta percreta was diagnosed when the placenta 
has invaded the myometrium and the perimetrium. The final 
pathologic diagnosis of placenta percreta was confirmed 
after delivery for every subject. The inclusion criteria were 
as follows: white Turkish female, history of one cesarean sec-
tion, singleton pregnancy with live fetus > 26 weeks of 
gestation (gestational age was determined from the date 
of the last menstrual period and conﬁrmed by means of 
ultrasound in the ﬁrst trimester). Exclusion criteria were as 
follows: twin gestation, infectious or hemorrhagic problems 
in the current pregnancy, neonate with congenital anomaly, 
prior two or more cesarean deliveries, systemic diseases 
(e.g. hypertensive, diabetic, cardiovascular, renal, thyroidal 
diseases, infectious diseases, diseases interfering with leu-
kocyte counts and functions), patients who had been using 
various drugs (painkillers, alcohol, cocaine), and smoking. In 
the end, 93 patients diagnosed with placenta previa (study 
group) and 247 pregnant patients (control group) were 
included in the study after the exclusion criteria had been 
applied. Local Ethics Committee approved of the study (no.: 
27.05.2013/29).
Hematologic parameters in the first and third trimester, 
demographic data (maternal age, body weight and height, 
gestational age at birth, birthweight (BW), gender of the 
neonate and previous reproductive history of the patients) 
were obtained from their medical records. All of the patients 
delivered via cesarean section due to PP or prior cesar-
ean section, so the mode of delivery was not included in the 
analysis. Normal C-Reactive Protein (CRP) levels as well as 
negative cervical and urinary culture results indicated that 
the high leukocyte counts were irrespective of any infectious 
process. BMI was defined as the weight in kilograms divided 
by the square of the height in meters (kg/m2). 
Hematologic parameters were analyzed with LH780 he-
matological analyzer (Beckman Coulter, Fullerton, CA, USA). 
All blood analyses were performed within two hours of 
blood sampling. Neutrophil-to-lymphocyte ratio (NLR) was 
calculated by proportioning absolute neutrophil count to 
absolute lymphocyte count. Likewise, platelet-to-lympho-
cyte ratio (PLR) was calculated as the ratio between the 
absolute platelet count and absolute lymphocyte count.
Patient demographic data and hematologic parameters 
were compared. Statistical Package for Social Sciences (SPSS, 
Chicago, IL, USA) version 17.0 for Windows was used for 
statistical analysis. Distribution of the data was analyzed 
with the Kolmogorov-Smirnov and the Shapiro Wilk test. 
Data were presented as mean with standard deviation or 
median with minimum and maximum values of ranges for 
continuous variables, and as number with percentage for 
categorical variables. Independent samples t-test was used 
for parametric variables and Mann-Whitney U test was used 
for non-parametric variables to compare the investigated 
groups. Proportions were compared with the Chi-square 
test or Fisher’s exact test. In all analyses, two-tailed p-values 
of < 0.05 were considered as statistically significant.
RESULTS
The two groups were similar with regard to age dis-
tribution (31.2 ± 5.1 years [mean ± SD] for the PP group 
and 31.7 ± 4.2 years for controls), BMI (27.7 ± 3.6 kg/m2 for 
the PP group and 27.4 ± 4.6 kg/m2 for controls), and ob-
stetric history (except number of abortions and curet-
tage) (Table 1). All study participants underwent a cesar-
ean section. Gestational age at birth (35.7 ± 3.3 weeks 
in the PP group and 38.6 ± 1.3 weeks in controls) and 
birthweight (2677.9 ± 744.2 grams in the PP group and 
3395.4 ± 385.2 grams in controls) were significantly lower in 
the PP group as compared to the control group (p < 0.001 for 
both groups) (Table 1). No neonatal deaths were recorded. 
All hematologic variables were statistically significantly 
different between the first and the third trimester, except 
for PLR (Table 2). 
Total leukocyte counts, neutrophil counts and neutro-
phil-to-lymphocyte ratios (NLRs) in the third trimester were 
significantly higher in the PP group as compared to controls 
(p = 0.034, p = 0.002 and p = 0.004, respectively) (Table 3). 
Mean platelet volume (MPV) and the ‘ratio of large platelets’ 
(P-LCR) values in the third trimester were significantly lower 
in the PP group as compared to controls (p = 0.001 and 
p = 0.003, respectively). There were no differences between 
groups in terms of lymphocyte counts, platelet counts, 
‘plateletcrit’ (PCT) and ‘platelet distribution width’ (PDW) 
values in the third trimester and all of the investigated pa-
rameters in the first trimester. 
Six out of 93 patients underwent hysterectomy because 
of adhesive placental abnormalities and all of the 6 pa-
tients were diagnosed with total placenta previa. The final 
pathologic diagnosis of placenta percreta was confirmed 
after delivery for every subject. None of them experienced 
any peri-operative or post-operative complications. The 
first trimester whole blood count of these 6 patients could 
not be obtained from the medical records, so analyses for 
their hematologic variables were performed with their 
third trimester values. Gestational age at birth time and 
birth weights of these six patients were significantly lower 
than the values of all other participants (p = 0.047 and 
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Table 1. Comparisons of some demographic and descriptive characteristics between two groups
Characteristics Placenta previa (n = 93) Control (n = 247) p value
Age (years) 31.2 ± 5.1 (18–42) 31.7 ± 4.2 (26–42) 0.33
BMI [kg/m2] 27.7 ± 3.6 (19.95–36.7) 27.4 ± 4.6 (16.73–41.09) 0.21
Gravidity 3 (1–10) 2 (1–9) 0.442
Parity 1 (0–8) 1 (0–6) 0.352
Living child 1 (0–8) 1 (0–6) 0.804
Abortus 0 (0–2) 0 (0–3) < 0.001
D & C 0 (0–5) 0 (0–5) 0.016
Gestational ages at birth (weeks) 35.7 ± 3.3 (26.14–40.28) 38.6 ± 1.3 (35–42) < 0.001
Birthweight [g] 2677.9 ± 744.2 (830–4040)
3395.4 ± 385.2 
(2580–4490) < 0.001
Results are presented as mean ± standard deviation (range) or median (range). BMI — body mass index; D & C — dilatation and curettage
Table 2. Comparisons of leukocytic and thrombocytic indices in all patients between first and third trimester of pregnancy
Characteristics First trimester Third trimester p value
Total leukocyte count 8984.74 ± 2093.16 10 260.58 ± 2317.12 < 0.001
Neutrophil count 6217.40 ± 1740.35 7534.10 ± 2109.70 < 0.001
Lymphocyte count 2020.50 ± 601.62 1932.40 ± 568.07 0.01
Platelet count (× 109/L) 244.61 ± 63.87 225.87 ± 63.13 < 0.001
Mean platelet volume (MPV) (femtoliter) 10.54 ± 1.01 10.73 ± 1.02 < 0.001
Platelet-crit (PCT) 0.25 ± 0.06 0.24 ± 0.06 < 0.001
Platelet distribution width (PDW) (%) 12.93 ± 2.28 13.74 ± 2.59 < 0.001
Ratio of large platelets (P-LCR) (%) 29.83 ± 7.70 30.81 ± 7.49 0.016
Neutrophil to lymphocyte ratios (NLR) 3.30 ± 1.36 4.32 ± 2.40 < 0.001
Platelet to lymphocyte ratios (PLR) 128.73 ± 42.0 126.17 ± 51.87 0.376
The data were given as mean ± standard deviation
Table 3. Comparisons of some haematologic parameters between two groups
Characteristics Placenta previa (n = 93) Control (n = 247) p value
WBC1 8701.11 ± 2369.21(4550–15 070)
9015.75 ± 2063.77 
(4300–14 670) 0.459
WBC3 10 834.73 ± 2591.77 (5920–20 490)
10 188.02 ± 2145.60 
(5540–16 300) 0.034
Neutrophil count in the 1st trimester 5.94 ± 1.81 (3.02–10.59) 6.25 ± 1.73 (2.40–11.6) 0.387
Neutrophil count in the 3rd trimester 8.21 ± 2.42 (3.68–18.43) 7.44 ± 1.89 (3.71–13.3) 0.002
WBC3/WBC1 ratio 1.28 ± 0.32 (0.76–1.96) 1.17 ± 0.31 (0.54–2.55) 0.090
NLR in the 1st trimester 3.20 ± 1.04 (1.58–6.00) 3.31 ± 1.39 (1.1–13.56) 0.998
NLR in the 3rd trimester 5.24 ± 3.55 (2.01–20.94) 4.11 ± 1.71 (1.83–14.54) 0.003
MPV in the 1st trimester 10.48 ± 1.17 (8.7–13.9) 10.54 ± 0.99 (7.4–13.1) 0.769
MPV in the 3rd trimester 10.35 ± 1.02 (8.3–12.8) 10.75 ± 1.01 (8.3–13.8) 0.001
P-LCR in the 1st trimester 29.13 ± 9.5 (15.4–55.9) 29.9 ± 7.5 (3.64–49.9) 0.625
P-LCR in the 3rd trimester 28.20 ± 7.44 (15.6–46) 30.91 ± 7.42 (13–53.4) 0.003
The data were given as the mean ± standard deviation (range). WBC1 — total leukocyte count in the first trimester; WBC3 — total leukocyte count in the third trimester; 
NLR — neutrophil to lymphocyte ratio; MPV — mean platelet volume; P-LCR — ratio of large platelets
370
Ginekologia Polska 2016, vol. 87, no. 5
www. journals.viamedica.pl/ginekologia_polska
p = 0.036, respectively). Gestational age at birth time of 
these six patients was significantly lower than values of 
other patients in the PP group (p = 0.046). Birth weights of 
neonates born to these 6 patients were lower, but without 
statistical significance, as compared to the others in the PP 
group (p = 0.061) (Table 4). 
Third trimester MPV values of the patients with placenta 
percreta were significantly lower than other patients in the 
PP group (p = 0.003), but also lower than all other patients in-
cluded in the study (p = 0.001). Likewise, third trimester P-LCR 
values of these patients were significantly lower than other 
patients in the PP group (p = 0.002), but also lower than all 
other subjects included in the study (p = 0.001). 
DISCUSSION
Similarity of demographic features such as age, BMI, 
and most obstetric history characteristics between the PP 
group and the control group increased the reliability and 
validity of the comparison. Previous curettage and abortion 
are widely known risk factors for the development of PP and 
our findings also confirmed that fact [1, 3]. Birth weight and 
gestational age at birth in the PP group were significantly 
lower as compared to controls. We attributed these results 
to the complicated pregnancies, especially hemorrhagic 
consequences which demand early delivery. Regardless, no 
neonatal deaths were noted. It may have been due to low-risk 
study samples, because we excluded patients with systemic 
diseases, history of two or more cesarean deliveries, prior 
infectious or hemorrhagic problems in the current pregnancy 
and other risk factors in order to provide an equal evaluation 
between the two groups at the very beginning of the study.
Considerable diversity of the hematologic parameters 
between the first and the third trimester made us think 
that pregnancy is a continuously changing process in itself. 
One study reported that the upper limit of leukocyte count 
increases from the first to the third trimester, which is con-
sistent with our findings [4]. Research about altered plasma 
volume and cellular content revealed that the increase in 
the WBC count was largely due to increases in circulating 
segmented neutrophils and granulocytes, whose absolute 
number was nearly doubled at term. It was said that the 
reason for the increased leukocytosis was still unclear, but it 
might have been caused by the elevated estrogen and corti-
sol levels [5]. In our study, platelet (PLT) counts of all patients 
in the first trimester were significantly higher than in the 
third trimester, which is again consistent with the literature. 
Pitkin and Witte [6] and O’Brien [7] showed that platelet 
counts were decreasing with advancing gestational age. In 
our study, MPV and P-LCR values of all patients in the third 
trimester were significantly higher than in the first trimester. 
Diminution of platelet counts and simultaneous enhance-
ment of their volume and distribution width over the third 
trimester might be caused by their destruction, regarding 
microangiopathic reasons, even in a normal pregnancy. It 
has been well-established in a study by Fay et al. [8]. 
Total leukocyte count, neutrophil count, neutro-
phil-to-lymphocyte ratio (NLR), MPV and P-LCR values in 
the third trimester were good predictors for the diagno-
sis of PP in our study. Other parameters like lymphocyte 
count, platelet count, PCT, and PDW values in the third 
trimester and all of the investigated hematologic param-
eters in the first trimester did not predict placenta previa. 
Neutrophil dominance in the PP group prompted us to think 
that an inflammatory process may take place in the third 
trimester because of PP. It could be caused by an ascend-
ing intrauterine and placental infection as a result of close 
proximity to the cervico-vaginal microbial colonization. It 
was well-established in a study by Park et al. [9]. Interestingly, 
there was no difference between patients with placenta 
percreta and patients with non-percreta placenta previa 
regarding neutrophil dominance in our study. Considering 
similar close proximity of the placenta to the uterine cervix in 
Table 4. Comparisons of characteristics between patients with and without placenta percreta in the group of placenta previa
Characteristics Placenta percreta (n = 6) Non-percreta placenta previa (n = 87) p value
Age (years) 31.67 ± 4.23 31.27 ± 5.05 0.853
BMI [kg/m2] 28.90 ± 3.14 27.70 ± 3.62 0.431
Gestational ages at birth (weeks) 33.16 ± 4.47 35.93 ± 3.12 0.046
Birthweight [g] 2130.0 ± 955.15 2720.57 ± 715.58 0.061
WBC3 10 925.0 ± 2984.89 10 817.27 ± 2479.48 0.92
Neutrophil count in the 3rd trimester 8655.0 ± 3010.94 8140.90 ± 2275.57 0.604
NLR in the 3rd trimester 5455.0 ± 2110.57 5161.9 ± 3608.57 0.845
MPV in the 3rd trimester 9.23 ± 0.59 10.48 ± 0.98 0.003
P-LCR in the 3rd trimester 20.65 ± 3.93 29.09 ± 7.20 0.002
The data were given as mean ± standard deviation. BMI — body mass index; WBC3 — total leukocyte count in the third trimester; NLR — neutrophil to lymphocyte 
ratio; MPV — mean platelet volume; P-LCR — ratio of large platelets
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these two groups, we can advocate the accuracy of the idea 
put forward by Park et al. [9]. However, we excluded patients 
with positive cervical culture result at the beginning of the 
study. Perhaps inflammatory processes in cervical tissue of 
the patients with placenta previa were non-infectious or 
infectious without bacterial colonization [10]. 
As it was repeatedly confirmed by previous studies, 
there is no ideal method to predict excessive hemorrhage in 
patients with placenta previa during the antepartum period 
because hemorrhage volume is known to be multifactorial, 
including PP-associated complications. The most common 
type of complications are adhesive placental disorders, 
especially placenta percreta. The sensitivity of ultrasound 
reached 90% to predict adhesive placental disorders, but 
there is still lack of evidence to predict the hemorrhage 
volume [11]. In addition, surgical complications significantly 
contribute to higher incidence of morbidity to baseline 
morbidity of placenta previa. 
In our study, all six patients with placenta percreta had 
significantly lower MPV and lower P-LCR values as compared 
to cases without placenta percreta (non-percreta placenta 
previa) in the third trimester. Alas, the literature sources 
offered no explanation for this finding. 
Our study was not without limitations. We were not able 
to access the first trimester hematologic variables of the six 
patients who were diagnosed with placenta percreta due 
to the fact that they were referred to our tertiary care hos-
pital from another institution. Another limitation was lack 
of evidence about the need for blood product transfusion 
and hemorrhage volume, which was caused by incomplete 
medical files. 
CONCLUSIONS
MPV and P-LCR values were found to be significantly 
lower in patients with placenta percreta than in patients with 
placenta previa non-percreta, and also were significantly 
decreased in all PP patients as compared to controls. These 
two parameters seem promising in distinguishing patients 
with adhesive placental complications from patients who 
have non-complicated placenta previa. Physio-pathologic 
mechanisms regarding these variabilities remain to be fully 
elucidated.
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